NK:IO
Developer of small molecule therapies for hematological and solid tumors
📍 London, United Kingdom · Oncology
Funding snapshot
Last roundSeed
Amount$127K
Date1 December 2024
About
Developer of small molecule therapies for hematological and solid tumors. The company is pioneering discoveries in small molecule and peptide ligand activation of blood stem cell progenitors and NK cells for the treatment of cancer.
Latest news
No articles yet.
Similar startups
PayFlow
Embedded payments infrastructure for Southeast Asian marketplaces and platforms.
GreenGrid
Software for planning and operating distributed battery storage across Europe.
Immuneel
Developer of T-cell therapies for the treatment of cancer
ImmunoACT
Developer of cell and gene therapies for cancer treatment